Patient Outcomes Reporting for Timely Assessments of Life with Depression: PORTAL-Depression
及时评估抑郁症生活的患者结果报告:门户抑郁症
基本信息
- 批准号:9753157
- 负责人:
- 金额:$ 37.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT ABSTRACT
In the last decade, there has been expansion of both health information technology by healthcare systems and
internet use by patients. This simultaneous growth provides a unique opportunity for healthcare systems to
collect patient-reported outcomes (PROs) and integrate PROs into clinical care by using patient portals. Patient
portals are secure websites that give patients access to their health information via a web connection. Early
studies have found that patients who use portals have higher levels of satisfaction and engagement. To date,
however, portals have not been used proactively by healthcare systems to systematically collect PROs.
Population-wide proactive collection of PROs would be valuable for identifying and managing patients with
depression. In primary care, major depressive disorder (MDD) is highly prevalent and is associated with
reduced quality of life and suicide. However, only 50% of patients in primary care receive recommended
annual screening, and only 50% of patients with MDD are treated adequately. Systematic measurement of
MDD symptoms can lead to increased treatment and greater rates of remission; however, many providers do
not routinely measure symptoms. The Computerized Adaptive Test for Mental Health (CAT-MH) is a recent
innovation in depression symptom measurement that could allow for efficient assessments. The CAT-MH is a
validated test that uses algorithms in real-time to ask the most diagnostically informative questions and
assesses mental health symptoms, including depression. In general, CATs could be ideal for engaging patients
in providing PROs because these tests are both very precise and very brief; however, to date, few CATs have
been integrated into EHRs. This study's goals are to integrate the CAT-MH into an EHR for a healthcare
system and evaluate the effectiveness of collecting depression symptoms via a patient portal (MyChart) vs.
usual collection during clinic visits in two randomized controlled trials. In Aim 1, among primary care patients
who are due for depression screening, we will determine whether MyChart CAT-MH depression screening
(population-based care) increases the number of screenings, compared to usual care. In Aim 2, among
primary care patients with active MDD, we will determine whether patients who receive MyChart depression
measurement (measurement-based care) have higher rates of MDD remission, compared to patients who
receive usual care. With these aims, this grant will provide essential information on the barriers and solutions
to integrating adaptive tests for PROs into EHRs, as well as evidence for the capability of patient portals for
providing proactive population-based patient-reported outcome measurement.
项目摘要
在过去的十年中,卫生保健系统和卫生信息技术都得到了发展
患者使用互联网的情况。这一同步增长为医疗保健系统提供了一个独特的机会
收集患者报告的结果(PRO),并使用患者门户将PRO集成到临床护理中。有耐心的
门户网站是安全的网站,让患者通过网络连接访问他们的健康信息。早些时候
研究发现,使用门户网站的患者有更高的满意度和参与度。到目前为止,
然而,医疗保健系统并没有主动使用门户来系统地收集专业人员。
在全人群范围内主动收集专业人员将对识别和管理患有
抑郁症。在初级保健中,严重抑郁障碍(MDD)非常普遍,并与
生活质量下降和自杀。然而,只有50%的初级保健患者得到了推荐
每年进行一次筛查,只有50%的MDD患者得到了适当的治疗。系统地测量
MDD症状可导致更多的治疗和更大的缓解率;然而,许多提供者确实如此
而不是常规地测量症状。心理健康计算机化适应性测验(CAT-MH)是最近发展起来的
抑郁症症状测量方面的创新,可以进行有效的评估。猫-MH是一种
经过验证的测试,使用算法实时提出最具诊断性信息的问题,并
评估精神健康症状,包括抑郁。总的来说,猫可能是吸引病人的理想选择。
因为这些测试既非常精确又非常简短;然而,到目前为止,很少有猫这样做
已被整合到EHR中。这项研究的目标是将CAT-MH整合到医疗保健的EHR中
系统并评估通过患者门户(MyChart)收集抑郁症状的有效性。
在两个随机对照试验中,通常在门诊期间收集数据。在目标1中,在初级保健患者中
谁应该进行抑郁症筛查,我们将确定MyChart CAT-MH抑郁症筛查是否
(基于人口的护理)与通常的护理相比,增加了筛查的数量。在目标2中,
初级保健活动的MDD患者,我们将确定患者是否接受MyChart抑郁症
与以下患者相比,测量(基于测量的护理)的MDD缓解率更高
接受通常的护理。基于这些目标,这笔赠款将提供有关障碍和解决办法的重要信息。
将专业人员的适应性测试整合到EHR中,以及患者门户功能的证据
提供积极主动的基于人群的患者报告结果衡量标准。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Neda Laiteerapong其他文献
Neda Laiteerapong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Neda Laiteerapong', 18)}}的其他基金
Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life with HIV and Substance Use (ePORTAL HIV-S)
实现患者结果报告的公平性,以便及时评估艾滋病毒感染者和药物使用的生活(ePORTAL HIV-S)
- 批准号:
10740440 - 财政年份:2023
- 资助金额:
$ 37.66万 - 项目类别:
Predicting and Reducing Future Health Disparities for U.S. Adults with Diabetes
预测和减少美国成人糖尿病患者未来的健康差异
- 批准号:
9912648 - 财政年份:2018
- 资助金额:
$ 37.66万 - 项目类别:
Predicting and Reducing Future Health Disparities for U.S. Adults with Diabetes
预测和减少美国成人糖尿病患者未来的健康差异
- 批准号:
9788527 - 财政年份:2018
- 资助金额:
$ 37.66万 - 项目类别:
Linking the Legacy Effect in Type 2 Diabetes to Clinical Decision Making
将 2 型糖尿病的遗留影响与临床决策联系起来
- 批准号:
8538972 - 财政年份:2012
- 资助金额:
$ 37.66万 - 项目类别:
Linking the Legacy Effect in Type 2 Diabetes to Clinical Decision Making
将 2 型糖尿病的遗留影响与临床决策联系起来
- 批准号:
8878245 - 财政年份:2012
- 资助金额:
$ 37.66万 - 项目类别:
Linking the Legacy Effect in Type 2 Diabetes to Clinical Decision Making
将 2 型糖尿病的遗留影响与临床决策联系起来
- 批准号:
8425302 - 财政年份:2012
- 资助金额:
$ 37.66万 - 项目类别:
Linking the Legacy Effect in Type 2 Diabetes to Clinical Decision Making
将 2 型糖尿病的遗留影响与临床决策联系起来
- 批准号:
8704929 - 财政年份:2012
- 资助金额:
$ 37.66万 - 项目类别:
相似海外基金
Implementation and Outcomes of Child Protection System Reporting Policies Regarding Infants Born with Prenatal Substance Exposure
关于出生前接触药物的婴儿的儿童保护系统报告政策的实施和成果
- 批准号:
10600289 - 财政年份:2023
- 资助金额:
$ 37.66万 - 项目类别:
Reporting of randomised trials using surrogate outcomes: development of extensions to the CONSORT 2010 and SPIRIT 2013 guidance statements
使用替代结果报告随机试验:开发 CONSORT 2010 和 SPIRIT 2013 指导声明的扩展
- 批准号:
MR/V038400/1 - 财政年份:2022
- 资助金额:
$ 37.66万 - 项目类别:
Research Grant
The Impact of Public Reporting on Procedural Outcomes Following Congenital Heart Surgery
公开报告对先天性心脏病手术后手术结果的影响
- 批准号:
10371685 - 财政年份:2022
- 资助金额:
$ 37.66万 - 项目类别:
Developing a Core Outcome Set for Perinatal Women with Generalized Anxiety Disorder (GAD): Standardizing the Measurement and Reporting of Treatment Outcomes
为患有广泛性焦虑症 (GAD) 的围产期妇女制定核心结果集:标准化治疗结果的测量和报告
- 批准号:
475488 - 财政年份:2022
- 资助金额:
$ 37.66万 - 项目类别:
Studentship Programs
The Impact of Public Reporting on Procedural Outcomes Following Congenital Heart Surgery
公开报告对先天性心脏病手术后手术结果的影响
- 批准号:
10557902 - 财政年份:2022
- 资助金额:
$ 37.66万 - 项目类别:
Advancing Population and Public health Reporting and Outcomes with Vaccination data Exchange (APPROVE)
通过疫苗接种数据交换推进人口和公共卫生报告和成果(批准)
- 批准号:
10351155 - 财政年份:2021
- 资助金额:
$ 37.66万 - 项目类别:
Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO)
季节性结膜炎爆发报告以预防和改善结果 (SCORPIO)
- 批准号:
10092776 - 财政年份:2021
- 资助金额:
$ 37.66万 - 项目类别:
Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO)
季节性结膜炎爆发报告以预防和改善结果 (SCORPIO)
- 批准号:
10571940 - 财政年份:2021
- 资助金额:
$ 37.66万 - 项目类别:
Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO)
季节性结膜炎爆发报告以预防和改善结果 (SCORPIO)
- 批准号:
10361393 - 财政年份:2021
- 资助金额:
$ 37.66万 - 项目类别:
Quantitative Reporting in Crohn’s Disease: Maximising available MRI data to better direct patient treatment, speed up treatment decisions and improve healthcare outcomes
克罗恩病的定量报告:最大限度地利用可用的 MRI 数据,以更好地指导患者治疗、加快治疗决策并改善医疗保健结果
- 批准号:
73477 - 财政年份:2020
- 资助金额:
$ 37.66万 - 项目类别:
Feasibility Studies














{{item.name}}会员




